Protein chips, a sophisticated protein microarray method, have emerged as a pivotal high-throughput approach in disease rate monitoring, clinical diagnostics, and large-scale biology experiments. Recent trends indicate a substantial increase in demand for protein chips, particularly in clinical research, diagnostics, and drug discovery segments. This surge can be attributed to the alarming rise in cancer prevalence, which remains a leading cause of approximately 10 million global deaths in 2020, as reported by the World Health Organization (WHO). In the same year, there were over 19 million new cancer cases, further highlighting the urgent need for advanced diagnostic tools.
Read More Insights: https://www.fairfieldmarketresearch.com/report/protein-chip-market
One of the driving factors behind the growing popularity of protein chips is the development of efficient, reliable, and advanced diagnostic technologies. Protein chips enable researchers to track a multitude of addressable protein-protein interactions, small molecule targets, protein-phospholipid interactions, and protein kinase substrates simultaneously, making them an invaluable tool in molecular biology and biochemistry. With the rise of personalized medicine, protein chip techniques are poised for even wider adoption.
Proteomics Key Revenue Generator; Diagnostics Promises Substantial Protein Chip Adoption
Proteomics, a significant revenue generator in the protein chip market, continues to find applications in drug discovery and biomedical research. Its continued preference can be attributed to its effectiveness in various applications, including chromatography, superficial fluid chromatography, X-ray crystallography, spectroscopy, protein fractionation, surface plasmon resonance, and electrophoresis. Proteomics provides a more accurate understanding of in-vivo outcomes, making it the preferred choice for research into disease pathogenesis, tumor resistance mechanisms, and therapeutic developments.
While protein functional analysis remains a sought-after application, the field of diagnostics holds massive potential for exponential growth in protein chip demand. The global COVID-19 pandemic has created numerous opportunities for protein chip market players, as biotech companies increasingly utilize protein chips for protein identification and protein-virus interaction studies. Given the extended timeline for global vaccination efforts, the demand for protein chips amid the pandemic is expected to remain robust.
Analyzing Protein Chip Adoption Based on Technology
Protein chip adoption is also influenced by underlying technology. Functional protein microarrays are expected to continue gaining traction in research studies related to protein function. Analytical microarrays and reverse phase protein microarrays are also projected to remain prominent technology types. Analytical microarrays, in particular, are seeing increased adoption due to lower costs and higher throughput.
Challenges to Market Growth
Despite the immense potential for advanced disease diagnostics, certain challenges hinder the long-term growth of the protein chip market. High-quality protein production in a high-throughput manner has been a persistent challenge for biotech companies. Additionally, maintaining the stability and quality of proteins for extended periods within a microarray is a critical requirement. The limited availability of high-quality proteins on the market continues to hamper market growth. Low protein yield with consistent quality and reliability remains a long-term growth limitation for the protein chip market.
In 2019, North America led the global protein chip market, closely followed by Europe. North America’s dominance is upheld by the strong presence of top biotech companies and significant funding for collaborative research. Europe is expected to benefit from the rising prevalence of cancer and growing interest in protein chips as a research tool. The European market benefits from top-notch healthcare quality, expanded healthcare infrastructure, and government support for molecular biology and biotechnological research.
The Asia Pacific region, led by China and India, is poised to exhibit remarkable performance in terms of protein chip adoption, especially in the diagnostics segment. The COVID-19 pandemic has further accelerated the use of protein chips in critical diagnosis.
Key Companies in Global Protein Chip Market
Key players in the global protein chip market include Sigma Aldrich Corporation, SEQUENOM, Inc., Biacore, EMD Millipore, Illumina, Inc., Agilent Technologies, Affymetrix, Inc., HTS Biosystems, Life Technologies Corporation, Ciphergen Biosystems, and Lumicyte.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/protein-chip-market
Visit Our Blogs:
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
This press release first seen on Brilad